NanoString Technologies Performance
| NSTGDelisted Stock | USD 4.11 0.22 5.08% |
The company secures a Beta (Market Risk) of 0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NanoString Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding NanoString Technologies is expected to be smaller as well. NanoString Technologies right now secures a risk of 0.0%. Please verify NanoString Technologies total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if NanoString Technologies will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days NanoString Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NanoString Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 107.1 M | |
| Total Cashflows From Investing Activities | 132.5 M |
NanoString |
NanoString Technologies Relative Risk vs. Return Landscape
If you would invest 411.00 in NanoString Technologies on September 2, 2024 and sell it today you would earn a total of 0.00 from holding NanoString Technologies or generate 0.0% return on investment over 90 days. NanoString Technologies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than NanoString, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NanoString Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NanoString Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NanoString Technologies, and traders can use it to determine the average amount a NanoString Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NSTG |
Based on monthly moving average NanoString Technologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NanoString Technologies by adding NanoString Technologies to a well-diversified portfolio.
NanoString Technologies Fundamentals Growth
NanoString Stock prices reflect investors' perceptions of the future prospects and financial health of NanoString Technologies, and NanoString Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NanoString Stock performance.
| Return On Equity | -10.29 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (1.02) % | |||
| Operating Margin | (0.76) % | |||
| Current Valuation | 153.97 M | |||
| Shares Outstanding | 48.12 M | |||
| Price To Earning | (4.62) X | |||
| Price To Book | 4.30 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 34.42 M | |||
| EBITDA | (42.19 M) | |||
| Cash And Equivalents | 272.34 M | |||
| Cash Per Share | 5.86 X | |||
| Total Debt | 250.5 M | |||
| Debt To Equity | 2.22 % | |||
| Book Value Per Share | (1.05) X | |||
| Cash Flow From Operations | (128.61 M) | |||
| Earnings Per Share | (3.53) X | |||
| Total Asset | 353.41 M | |||
| Retained Earnings | (809.3 M) | |||
| Current Asset | 82.79 M | |||
| Current Liabilities | 20.91 M | |||
About NanoString Technologies Performance
By analyzing NanoString Technologies' fundamental ratios, stakeholders can gain valuable insights into NanoString Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NanoString Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NanoString Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. Nanostring Tech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 766 people.Things to note about NanoString Technologies performance evaluation
Checking the ongoing alerts about NanoString Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NanoString Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NanoString Technologies is not yet fully synchronised with the market data | |
| NanoString Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.42 M. Net Loss for the year was (159.54 M) with profit before overhead, payroll, taxes, and interest of 61.79 M. | |
| NanoString Technologies currently holds about 272.34 M in cash with (128.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Providence Wealth Advisors LLC Grows Stock Position in Seres Therapeutics, Inc. |
- Analyzing NanoString Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NanoString Technologies' stock is overvalued or undervalued compared to its peers.
- Examining NanoString Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NanoString Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NanoString Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NanoString Technologies' stock. These opinions can provide insight into NanoString Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in NanoString Stock
If you are still planning to invest in NanoString Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NanoString Technologies' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |